ClickCease
Peer-Reviewed Research: TCM for COVID-19 and Long-COVID Recovery
This peer-reviewed study, published in the Journal of Herbal Medicine, explores the effectiveness of Traditional Chinese Medicine (TCM) in treating both acute COVID-19 and long-COVID symptoms. Using a combination of meta-analysis and retrospective clinical data, the research highlights how TCM—specifically the Qū Dú Qiáng Fèi Yī Hào Fāng Mod. 3 formula—significantly reduced fatigue, muscle pain, and other lingering symptoms in long-COVID patients. The findings support TCM as a powerful adjunctive therapy that addresses both physical and neurological post-viral symptoms.
 
Properties of the Novel Chinese Herbal Medicine Formula Qu Du Qiang Fei I Hao Fang Warrant Further Research to Determine Its Clinical Efficacy in COVID-19 Treatment
The study titled "Properties of the Novel Chinese Herbal Medicine Formula Qu Du Qiang Fei I Hao Fang Warrant Further Research to Determine Its Clinical Efficacy in COVID-19 Treatment" was published in Medical Acupuncture, Volume 33, Issue 1, in 2021. This research investigates the therapeutic effects of the Chinese herbal medicine formula Qu Du Qiang Fei I Hao Fang (QDQF1), also known as "Eliminating Virus and Strengthening Lung—No.1 Formula," in the context of COVID-19 treatment. The study suggests that QDQF1 may offer potential benefits in managing COVID-19 symptoms, warranting further clinical research to establish its efficacy.
 
A Feasibility Study on Treatment of Uterine Fibroids with Tung’s Acupuncture
The study titled "A Feasibility Study on Treatment of Uterine Fibroids with Tung’s Acupuncture" was published in Medical Acupuncture, Volume 31, Issue 6, in 2019. The authors are Jennifer Cruz, Linda Carrington, and Harry Hong. This study evaluates the feasibility of conducting clinical trials on the treatment of uterine fibroids (UFs) and related symptoms using a 7-point Tung's acupuncture protocol.

Study Overview:

• Participants: Nine individuals meeting the study criteria were recruited into two treatment groups: a 6-week group (5 participants) and a 12-week group (4 participants).
•Treatment Protocol: Acupuncture sessions were administered twice a week.

•Assessment Methods:
• Ultrasound Examinations: Conducted before and after the treatment program to evaluate uterine size, number of fibroids, and volume.
• Symptom Survey Questionnaire (SSQ): Participants completed this questionnaire, assessing 14 symptoms, at each acupuncture session.

Results:

• All nine participants completed the program.
• No adverse responses or concerns were reported.
• After 6 weeks of treatment, all eight subjects (excluding one due to age limit) reported improvement in SSQ scores.
• Reduction in scores for 10 of the 14 surveyed symptoms was statistically significant.
• The 12-week group exhibited a higher percentage reduction in symptoms compared to the 6-week group.
• After 12 weeks, nine of the 14 surveyed symptoms were completely eliminated.

• Conclusion: The study suggests that acupuncture may reduce symptoms related to uterine fibroids. It is feasible to conduct larger clinical trials with a more extensive sample size. However, due to technical issues, changes in uterine size and fibroid volume could not be adequately determined.